Kaiser Permanente 3-year study is one of the longest to study high-risk patients managing diabetes with continuous glucose monitors.

Kaiser Permanente 3-year study is one of the longest to study high-risk patients managing diabetes with continuous glucose monitors. New study also highlights need to increase awareness of trials ...

Shannon N. Ogden, PhD, MPH, is a Postdoctoral Research Fellow at the Kaiser Permanente Division of Research. Dr. Ogden’s research interests lie in the implementation and evaluation of policies and ...

BACKGROUND: Prelicensure clinical studies may not include sufficient numbers of subjects to assess the potential for rare postvaccination adverse events. The aim of this postlicensure study ...

One-year review of ambient scribe technology at The Permanente Medical Group finds evidence it could reduce documentation burden A year into the rollout of a generative artificial intelligence (AI) ...

The vaccine currently used to protect people against shingles maintains strong effectiveness over 4 years post-vaccination, according to a Kaiser Permanente-led research study published in Annals of ...

Clinical documentation in the electronic health record (EHR) has become increasingly burdensome for physicians and is a major driver of clinician burnout and dissatisfaction. Time dedicated to ...

Kaiser Permanente study identifies factors that could help doctors determine which patients are most likely to achieve this goal A diagnosis of type 2 diabetes typically means a future of blood sugar ...

A follow-up program for Kaiser Permanente Northern California (KPNC) patients discharged from the hospital was associated with reduced readmissions without increased mortality, new research in the ...

Kaiser Permanente Northern California’s life-saving Advance Alert Monitor (AAM) program — an early detection system that helps care teams predict when hospitalized patients are at risk for clinical ...

Kaiser Permanente vaccine researchers report long-term study of Zostavax, no longer used in U.S. The original vaccine against shingles — Zostavax, a live shingles vaccine no longer used in the U.S. — ...

New analyses of maternal cannabis use during early pregnancy find no evidence of increased risk of early developmental delays up to age 5 or of autism spectrum disorder. The studies were published in ...